Skip to main content
INNOVA CAPTAB LIMITED logo

INNOVA CAPTAB LIMITED — Investor Relations & Filings

Ticker · INNOVACAP ISIN · INE0DUT01020 LEI · 549300SNL5HFUHE66804 BSE.NS Manufacturing
Open in API
Filings indexed 212 across all filing types
Latest filing 2025-12-29 Regulatory Filings
Country IN India
Listing BSE.NS INNOVACAP

About INNOVA CAPTAB LIMITED

https://www.innovacaptab.com

Innova Captab Limited is an integrated pharmaceutical company focused on the research, development, manufacturing, and marketing of a wide range of pharmaceutical formulations. The company operates primarily as a Contract Development and Manufacturing Organization (CDMO), providing comprehensive services to leading domestic and international pharmaceutical brands. Its product portfolio includes diverse dosage forms such as tablets, capsules, dry syrups, ointments, and injections across multiple therapeutic areas, including anti-infectives, analgesics, and gastrointestinal treatments. Innova Captab maintains a strong emphasis on R&D and quality control, operating advanced manufacturing facilities that adhere to global regulatory standards. In addition to its CDMO business, the company manages a domestic branded generics division and an international export business, catering to a global clientele with a focus on high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter from Innova Captab Limited addressed to stock exchanges (BSE and NSE) informing about the closure of the trading window for insiders due to upcoming unaudited financial results for the quarter and nine months ending December 31, 2025. It references regulatory compliance with SEBI (Prohibition of Insider Trading) Regulations and mentions the trading window closure period but does not contain any financial data or results itself. The document is short (1813 characters) and serves as an announcement related to trading restrictions ahead of financial results, not the results or report itself. Therefore, it is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2025-12-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) informing them about the schedule of analyst and institutional investor meetings. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The content is about announcing the schedule of meetings with investors and analysts, explicitly stating that no unpublished price sensitive information will be discussed. The document length is 2010 characters, which is relatively short and does not contain any financial data, results, or detailed reports. It is an announcement of a meeting schedule rather than a financial report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-12-10 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 95% confidence The document is a letter dated 15th November 2025 from Innova Captab Limited addressed to stock exchanges (BSE and NSE). It informs about the schedule of analyst and institutional investor meetings, specifically an upcoming investor conference on 21st November 2025. The letter states that discussions will be based only on publicly available information and no unpublished price sensitive information will be shared. There are no financial statements, detailed financial data, or report content included. The document is an announcement of an event related to investor relations, not a financial report or earnings release. It fits the category of Investor Presentation announcements or meeting schedule notifications. Given the definitions, this is best classified as an Investor Presentation (IP) type document, as it relates to investor meetings and presentations. The document length is short and it is not a report publication announcement or regulatory filing. Confidence is high due to clear content and context.
2025-11-15 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call held by Innova Captab Limited on November 10, 2025, discussing the financial and operational performance for Q2 and H1 FY 2026. It includes management commentary, financial highlights, and a Q&A session with analysts. The presence of detailed financial figures, discussion of revenue, EBITDA, margins, and outlook confirms this is a full transcript of an earnings call rather than a brief earnings release or a summary. The document length is substantial (15,000 characters), and it contains the full text of the call, not just an announcement or a link to a report. Therefore, the appropriate classification is Call Transcript (CT).
2025-11-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the availability of an audio recording of an earnings call for the quarter and half year ended 30th September 2025. It references Regulation 30 of the SEBI Listing Regulations, which pertains to disclosure requirements. The document does not contain actual financial data or detailed financial results but rather informs about the availability of the earnings call recording on the company's website. The document length is short (1810 characters), and it serves as an announcement rather than the earnings release itself. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement about the earnings call recording availability, not the earnings release or transcript itself.
2025-11-10 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) dated 8th November 2025. It informs about the approval of the unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2025 by the Board of Directors. It also mentions the submission of a newspaper advertisement extract pursuant to SEBI regulations. The document does not contain the actual financial results or detailed financial statements but rather an announcement of the approval and publication of these results. The length is about 15,000 characters, but the content is primarily an announcement and submission of a newspaper advertisement extract, not the full financial report itself. Therefore, according to the MENU VS MEAL rule, this document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement related to financial results but does not contain the full report or detailed financial data.
2025-11-08 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.